China Universal Asset Management Co. Ltd. raised its holdings in Phibro Animal Health Co. (NASDAQ:PAHC – Free Report) by 358.6% in the fourth quarter, Holdings Channel reports. The fund owned 2,357 shares of the company’s stock after buying an additional 1,843 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Phibro Animal Health were worth $27,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the business. Brandes Investment Partners LP increased its holdings in shares of Phibro Animal Health by 38.5% during the 3rd quarter. Brandes Investment Partners LP now owns 1,873,300 shares of the company’s stock worth $23,922,000 after buying an additional 520,697 shares during the last quarter. Comerica Bank acquired a new stake in shares of Phibro Animal Health during the 2nd quarter worth approximately $3,877,000. BlackRock Inc. increased its holdings in shares of Phibro Animal Health by 5.7% during the 1st quarter. BlackRock Inc. now owns 3,789,646 shares of the company’s stock worth $75,604,000 after buying an additional 203,652 shares during the last quarter. Morgan Stanley increased its holdings in shares of Phibro Animal Health by 64.5% during the 4th quarter. Morgan Stanley now owns 467,638 shares of the company’s stock worth $6,271,000 after buying an additional 183,420 shares during the last quarter. Finally, AQR Capital Management LLC increased its holdings in shares of Phibro Animal Health by 106.6% during the 4th quarter. AQR Capital Management LLC now owns 271,247 shares of the company’s stock worth $3,637,000 after buying an additional 139,958 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.
Phibro Animal Health Stock Performance
NASDAQ:PAHC opened at $12.81 on Monday. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.60 and a current ratio of 3.12. The stock has a market capitalization of $518.81 million, a P/E ratio of 35.58, a PEG ratio of 4.74 and a beta of 0.75. The company has a 50 day moving average price of $12.33 and a 200 day moving average price of $11.73. Phibro Animal Health Co. has a fifty-two week low of $9.40 and a fifty-two week high of $15.98.
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Wednesday, March 6th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.75%. Phibro Animal Health’s payout ratio is currently 133.33%.
Wall Street Analysts Forecast Growth
Separately, StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, March 29th.
Check Out Our Latest Stock Analysis on PAHC
About Phibro Animal Health
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Further Reading
- Five stocks we like better than Phibro Animal Health
- How to Use the MarketBeat Excel Dividend Calculator
- MarketBeat Week in Review – 4/1 – 4/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Beazer Homes USA is an Overlooked Opportunity in Housing
- Investing in the High PE Growth Stocks
- 5 Stocks in the Current Bull Market with Upside to Come
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Co. (NASDAQ:PAHC – Free Report).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.